• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26920
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vascular Dissection (3160)
Event Date 09/10/2018
Event Type  Injury  
Event Description
Eminent clinical study: it was reported that the subject experienced a dissection, requiring an additional stent.Baseline rutherford classification was performed on the subject which revealed category 2 moderate claudication.Baseline angiography analysis of the right distal superficial femoral artery (sfa) involving the proximal popliteal artery (ppa) revealed no calcification, with absence of thrombus, ulceration, or aneurysm.Inflow tract patency (stenosis less than 50%) was observed.The subject therefore underwent treatment with these 6x80x130 and 6x60x130 innova stents as part of the eminent clinical trial.The 90% stenosed target lesion was located in the right distal sfa involving the ppa and was 60mm long with a proximal reference vessel diameter of 6mm and distal reference vessel diameter of 6mm and was classified as transatlantic intersociety consensus (tasc) ii b lesion.During the procedure, pre-dilation of the target lesion was performed followed by placement of the 6mm x 60mm study stent.A subsequent dissection occurred in the distal sfa post stent placement.Therefore, an additional 6mm x 80mm study stent was placed.Following post-dilation, the residual stenosis was 5%.The subject was discharged with antiplatelet therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17238795
MDR Text Key318210091
Report Number2124215-2023-33762
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 06/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/29/2021
Device Model Number26920
Device Catalogue Number26920
Device Lot Number0022442263
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/20/2023
Initial Date FDA Received06/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/30/2018
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-